617MO Safety and tolerability of INCB123667, a selective CDK2 inhibitor, in patients (pts) with advanced solid tumors: A phase I study.
Saved in:
| Title: | 617MO Safety and tolerability of INCB123667, a selective CDK2 inhibitor, in patients (pts) with advanced solid tumors: A phase I study. |
|---|---|
| Authors: | Simonelli, M.1 (AUTHOR), Lorusso, D.2 (AUTHOR), Homicsko, K.3 (AUTHOR), Seguy, F.4 (AUTHOR), Kinder, M.5 (AUTHOR), Liu, Q.6 (AUTHOR), Croft, E.7 (AUTHOR), Kitano, S.8 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 2, Vol. 35, pS495-S495. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2024.08.684 |
